COVID-19 Liver Injury Whether due to Virus or Medication: A Case Report

Abstract

Mild cases of liver injury had been found on COVID-19 cases worldwide. However, the growing prevalence and severity of the cases indicated the dangerous spread of liver impairment to a considerable amount of the population. A 59-year-old COVID positive man come to the emergency room with fever, cough, and nausea. He was treated with favipiravir, azithromycin and other symptomatic drugs. On the seventh day of treatment, patient had a significant increased in liver enzymes, AST was 162 U/L dan ALT was 465 U/L. Patient was diagnosed with acute liver injury. Favipiravir was stopped and he was given hepatoprotection agents. On the tenth day patient had no complaint and was discharged. COVID-19 patients have high risk of impaired liver function, either because of the infection treatment drugs. Administration of hepatoprotective agents and discontinuation of suspected drugs suspected should benefits the patients.